Synapse - Helena Yu

Search Within

Helena Alexandra Yu

Results (292)

Identifying early and late hallmarks of plasticity in neuroendocrine transformation of lung cancer at single-cell level

Meeting Abstract

Chan, J. M.; Quintanal-Villalonga, A.; Sabet, A.; Manoj, P.; Masilionis, I.; Falcon, C.; Sohail, N.; Chun, J.; Nawy, T.; Mazutis, L.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC following EGFRTKI and platinum-based chemotherapy: HERTHENA-Lung01

Meeting Abstract

Yu, H. A.; Goto, Y.; Hayashi, H.; Felip, E.; Yang, J. C. H.; Reck, M.; Yoh, K.; Lee, S. H.; Paz-Ares, L.; Besse, B.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

AI serial image prediction of progression-free survival (PFS) for locally advanced non-small cell lung cancer (LA-NSCLC) patients treated with chemoradiation (CRT) and durvalumab consolidation

Meeting Abstract

Veeraraghavan, H.; Jiang, J.; Jee, J.; Lebow, E. S.; Deasy, J. O.; Rimner, A.; Shaverdian, N.; Yu, H.; Gomez, D. R.
International Journal of Radiation Oncology, Biology, Physics (2023)

Fulltext@MSK | Save

Safety, tolerability, and antitumor activity of zipalertinib among patients with non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions

Journal Article

Piotrowska, Z.; Tan, D. S. W.; Smit, E. F.; Spira, A. I.; Soo, R. A.; Nguyen, D.; Lee, V. H. F.; Yang, J. C. H.; Velcheti, V.; Wrangle, J. M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Osimertinib and selpercatinib efficacy, safety, and resistance in a multicenter, prospectively treated cohort of EGFR-mutant and RET fusion-positive lung cancers

Journal Article

Rotow, J.; Patel, J. D.; Hanley, M. P.; Yu, H.; Awad, M.; Goldman, J. W.; Nechushtan, H.; Scheffler, M.; Kuo, C. H. S.; Rajappa, S.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

A phase 1 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with glioblastoma or non–small-cell lung cancer

Meeting Abstract

Johnson, M. L.; Henry, J. T.; Spira, A. I.; Battiste, J.; Alnahhas, I.; Ahluwalia, M. S.; Barve, M. A.; Edenfield, W. J.; Nam, D. H.; Eathiraj, S.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinical outcomes and genomic landscape of patients (pts) with EGFR-mutant lung cancer (EGFR+ LC) with central nervous system (CNS) metastases (mets)

Meeting Abstract

Sui, J. S. Y.; Wilcox, J.; Tischfield, S.; Choudhury, N. J.; Riely, G. J.; Kris, M. G.; Boire, A. A.; Yu, H. A.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Predictors of benefit to radiation for oligoprogressive disease in EGFR -mutant metastatic non-small cell lung cancer patients treated with osimertinib

Meeting Abstract

Chen, M. F.; Ma, J.; Kris, M. G.; Gomez, D. R.; Yu, H. A.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinical and genomic landscape of EGFR -mutant lung cancers (LCs) with squamous and adenosquamous differentiation

Meeting Abstract

Elkrief, A.; Falcon, C. J.; Richards, A. L.; Dymun, A.; Paik, P. K.; Aly, R. G.; Rekhtman, N.; Rudin, C. M.; Quintanal-Villalonga, A.; Yu, H. A.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Detection of MET amplification (METamp) in patients with EGFR mutant (m) NSCLC after first-line (1L) osimertinib

Meeting Abstract

Yu, H. A.; Kerr, K.; Rolfo, C. D.; Fang, J.; Finocchiaro, G.; Wong, K. H.; Veillon, R.; Kato, T.; Yang, J. C. H.; Nadal, E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save